MAOA and melanoma: Recent studies have shown that immune-cell-derived MAOA promotes an immunosuppressive tumor microenvironment by disrupting T cell and macrophage differentiation in mice, and that combining MAOI and anti-PD-1 treatments resulted in synergistic tumor suppression in melanoma and colon cancer (58, 59).